Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence

Identifieur interne : 001A78 ( Main/Exploration ); précédent : 001A77; suivant : 001A79

Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence

Auteurs : Theodore Kelesidis [Grèce] ; Iosif Kelesidis [Grèce] ; Petros I. Rafailidis [Grèce] ; Matthew E. Falagas [Grèce, États-Unis]

Source :

RBID : ISTEX:D7E236BC54A2D7242EB15874DC213D3B59ABF6A0

Abstract

There is growing universal concern regarding counterfeit medications. In particular, counterfeit antimicrobial drugs are a threat to public health with many devastating consequences for patients; increased mortality and morbidity and emergence of drug resistance. In addition, physicians treating these patients lose their confidence in the medications used and report high levels of bacterial resistance. The problem with fake and suboptimal medications got worse with the advent of the World Wide Web; a significant proportion of medications that are sold through Internet pharmacies is counterfeit. Various initiatives of the WHO (the International Medical Products Anti-Counterfeiting Taskforce) are hopefully going to tackle this very important public health issue. In this article, we review the available evidence in peer-reviewed articles and World Wide Web information resources regarding the issue of counterfeit antimicrobials.

Url:
DOI: 10.1093/jac/dkm109


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence</title>
<author>
<name sortKey="Kelesidis, Theodore" sort="Kelesidis, Theodore" uniqKey="Kelesidis T" first="Theodore" last="Kelesidis">Theodore Kelesidis</name>
</author>
<author>
<name sortKey="Kelesidis, Iosif" sort="Kelesidis, Iosif" uniqKey="Kelesidis I" first="Iosif" last="Kelesidis">Iosif Kelesidis</name>
</author>
<author>
<name sortKey="Rafailidis, Petros I" sort="Rafailidis, Petros I" uniqKey="Rafailidis P" first="Petros I." last="Rafailidis">Petros I. Rafailidis</name>
</author>
<author>
<name sortKey="Falagas, Matthew E" sort="Falagas, Matthew E" uniqKey="Falagas M" first="Matthew E." last="Falagas">Matthew E. Falagas</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D7E236BC54A2D7242EB15874DC213D3B59ABF6A0</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1093/jac/dkm109</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-SC658PZ7-K/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F30</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F30</idno>
<idno type="wicri:Area/Istex/Curation">000F30</idno>
<idno type="wicri:Area/Istex/Checkpoint">000961</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000961</idno>
<idno type="wicri:doubleKey">0305-7453:2007:Kelesidis T:counterfeit:or:substandard</idno>
<idno type="wicri:Area/Main/Merge">001A89</idno>
<idno type="wicri:Area/Main/Curation">001A78</idno>
<idno type="wicri:Area/Main/Exploration">001A78</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence</title>
<author>
<name sortKey="Kelesidis, Theodore" sort="Kelesidis, Theodore" uniqKey="Kelesidis T" first="Theodore" last="Kelesidis">Theodore Kelesidis</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Alfa Institute of Biomedical Sciences (AIBS), Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kelesidis, Iosif" sort="Kelesidis, Iosif" uniqKey="Kelesidis I" first="Iosif" last="Kelesidis">Iosif Kelesidis</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Alfa Institute of Biomedical Sciences (AIBS), Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rafailidis, Petros I" sort="Rafailidis, Petros I" uniqKey="Rafailidis P" first="Petros I." last="Rafailidis">Petros I. Rafailidis</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Alfa Institute of Biomedical Sciences (AIBS), Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Falagas, Matthew E" sort="Falagas, Matthew E" uniqKey="Falagas M" first="Matthew E." last="Falagas">Matthew E. Falagas</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Alfa Institute of Biomedical Sciences (AIBS), Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Tufts University School of Medicine, Boston, MA</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Grèce</country>
</affiliation>
<affiliation wicri:level="3">
<country wicri:rule="url">Grèce</country>
<wicri:regionArea>Correspondence address. Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Antimicrobial Chemotherapy</title>
<idno type="ISSN">0305-7453</idno>
<idno type="eISSN">1460-2091</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date when="2007-08">2007</date>
<date type="e-published" when="2007-06-05">2007</date>
<biblScope unit="vol">60</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="214">214</biblScope>
<biblScope unit="page" to="236">236</biblScope>
</imprint>
<idno type="ISSN">0305-7453</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0305-7453</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">There is growing universal concern regarding counterfeit medications. In particular, counterfeit antimicrobial drugs are a threat to public health with many devastating consequences for patients; increased mortality and morbidity and emergence of drug resistance. In addition, physicians treating these patients lose their confidence in the medications used and report high levels of bacterial resistance. The problem with fake and suboptimal medications got worse with the advent of the World Wide Web; a significant proportion of medications that are sold through Internet pharmacies is counterfeit. Various initiatives of the WHO (the International Medical Products Anti-Counterfeiting Taskforce) are hopefully going to tackle this very important public health issue. In this article, we review the available evidence in peer-reviewed articles and World Wide Web information resources regarding the issue of counterfeit antimicrobials.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Grèce</li>
<li>États-Unis</li>
</country>
<region>
<li>Attique (région)</li>
<li>Massachusetts</li>
</region>
<settlement>
<li>Athènes</li>
</settlement>
</list>
<tree>
<country name="Grèce">
<region name="Attique (région)">
<name sortKey="Kelesidis, Theodore" sort="Kelesidis, Theodore" uniqKey="Kelesidis T" first="Theodore" last="Kelesidis">Theodore Kelesidis</name>
</region>
<name sortKey="Falagas, Matthew E" sort="Falagas, Matthew E" uniqKey="Falagas M" first="Matthew E." last="Falagas">Matthew E. Falagas</name>
<name sortKey="Falagas, Matthew E" sort="Falagas, Matthew E" uniqKey="Falagas M" first="Matthew E." last="Falagas">Matthew E. Falagas</name>
<name sortKey="Falagas, Matthew E" sort="Falagas, Matthew E" uniqKey="Falagas M" first="Matthew E." last="Falagas">Matthew E. Falagas</name>
<name sortKey="Kelesidis, Iosif" sort="Kelesidis, Iosif" uniqKey="Kelesidis I" first="Iosif" last="Kelesidis">Iosif Kelesidis</name>
<name sortKey="Rafailidis, Petros I" sort="Rafailidis, Petros I" uniqKey="Rafailidis P" first="Petros I." last="Rafailidis">Petros I. Rafailidis</name>
</country>
<country name="États-Unis">
<region name="Massachusetts">
<name sortKey="Falagas, Matthew E" sort="Falagas, Matthew E" uniqKey="Falagas M" first="Matthew E." last="Falagas">Matthew E. Falagas</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A78 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001A78 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D7E236BC54A2D7242EB15874DC213D3B59ABF6A0
   |texte=   Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021